During the past decade, Rockefeller University Hospital conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 7 clinical trials were completed, i.e. on average, 77.8% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 4 clinical trials were completed. i.e. 133.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Rockefeller University Hospital" #1 sponsor was "Rockefeller University" with 35 trials, followed by "International AIDS Vaccine Initiative" with 2 trials sponsored, "Mary Sullivan-Whalen" with 2 trials sponsored, "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 1 trials sponsored and "Gilead Sciences" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Rockefeller University Hospital" #1 collaborator was "Aaron Diamond AIDS Research Center" with 5 trials as a collaborator, "National Institute of Allergy and Infectious Diseases (NIAID)" with 3 trials as a collaborator, "Facet Biotech" with 2 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 2 trials as a collaborator and "St. Luke's-Roosevelt Hospital Center" with 2 trials as a collaborator. Other collaborators include 20 different institutions and companies that were collaborators in the rest 27 trials.

According to Clinical.Site data, the most researched conditions in "Rockefeller University Hospital" are "HIV Infections" (6 trials), "Obesity" (6 trials), "Hepatitis C" (4 trials), "Insulin Resistance" (3 trials) and "HIV Infection" (2 trials). Many other conditions were trialed in "Rockefeller University Hospital" in a lesser frequency.

Most popular intervention types in "Rockefeller University Hospital" are "Drug" (18 trials), "Behavioral" (4 trials), "Biological" (4 trials), "Device" (4 trials) and "Other" (4 trials). Other intervention types were less common.

The name of intervention was led by "Daclizumab" (2 trials), "tin mesoporphyrin" (2 trials), "ADMVA" (1 trials), "ADVAX" (1 trials) and "Antiretroviral therapy" (1 trials). Other intervention names were less common.

The vast majority of trials in "Rockefeller University Hospital" are 40 trials for "All" genders, 4 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Rockefeller University Hospital". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 34 completed trials in Rockefeller University Hospital, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Rockefeller University Hospital, 14 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 11 trials that are defined as “Not Applicable".